Stephan B.Rosenfeld, MD

Medical Oncologist

Stephan B.Rosenfeld

Dr. Stephan B. Rosenfeld has been a practicing medical oncologist and hematologist with Highlands Oncology since July of 2002. After receiving his medical degree from the Chicago Medical School in 1996, Dr. Rosenfeld completed a three-year residency in internal medicine and a three year fellowship in hematology, oncology, and blood and marrow transplantation from the University of Iowa Hospitals and Clinics in Iowa City. Dr. Rosenfeld is board certified in internal medicine, hematology, and medical oncology from the American Board of Internal Medicine. He is also a member of several professional societies such as the American Society of Hematology, American Society of Clinical Oncology, and the Arkansas Medical Society.

Highlands

in the News

Our team is dedicated to staying at the forefront of oncology, and we are proud to share their latest advancements and recognition.

Surgeon highlights rising colorectal cancer cases among young adults

As March marks Colorectal Cancer Awareness Month, one doctor says he has seen an increase in cases in young adults.

According to the World Health Organization, colorectal cancer is now ranked as the third most common cancer worldwide and the second leading cause of cancer-related fatalities.

Highlands Oncology receives innovator award

Springdale-based Highlands Oncology, the region’s largest cancer-care provider, recently received a 2025 Association of Cancer Care Centers (ACCC) Innovator Award.

New cancer vaccine trial underway at Highlands Oncology in NW Arkansas

Some are calling it the research of the future — an mRNA vaccine to aid in cancer research.

There's an experimental trial for the vaccine that's been going on for the past year at Highlands Oncology in Springdale.

Simple, free, life-saving; Screening detects lung cancer early

As Joanna Thompson thinks back to the many lung cancer screenings she’s done over the years at Highlands Oncology in Springdale, one patient always springs to mind — the very first one whose screening revealed cancer in its early stages.